Trial intelligence / Profile preview

Valsartan in Type 2 Diabetes With and Without Coronary Artery Disease

NCT00982358Phase 4Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Jul 2004
Primary completion
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of valsartan in type 2 diabetes mellitus (T2DM), hypertension (HTN), coronary artery disease (CAD), sponsored by Charité – Universitätsmedizin Berlin. Started Jul 2004; status: completed.

02

Drugs

valsartan
03

Conditions

type 2 diabetes mellitus (T2DM)hypertension (HTN)coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00982358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00982358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call